Drugs / ParaGard® TCu380A
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03124160 Comparator | May 2017 → Jun 2022 | — | FHI 360 | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ParaGard TCu380A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03124160 ↗ |
| Route | Other | “inserted into the uterine cavity.” NCT03124160 ↗ |